Science and Tech

WHO has presented an update on the current situation on Omicron

·         WHO said that given the predominant circulation of the Delta variant in several countries, its too early to draw a conclusion on the impact of the new omicron variant on the worldwide epidemiology of Covid-19.

·         At constant time, World Health Organization has additionally conferred an update on the present situation on four key problems on omicron — transmissibility, clinical severity, risk of reinfection and also the potential impact of the vaccines.

·         WHO said that at this time, whereas “there appears to be proof that the omicron might have a growth advantage over different circulating variants, its unknown whether or not this can translate into increased transmissibility”.

·         WHO underlined that presently solely limited information are available on clinical severity creating it “challenging to assess any changes in malady severity with the omicron variant”.

·         WHO said that initial modelling studies from south africa have found an increased risk of re-infection, adding, this info solely offers an initial assessment of the danger of re-infection.

·         WHO reiterated that Interleukin-6 Receptor Blockers and corticosteroids are expected to still be effective within the management of patients with severe diseases.